Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gheorghe Doros

Showing results (11-20 of 291) with videos related to

Pageof 30
Sort By:
Blood Cancer Journal|July 5, 2022
Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian AmericansAndrew Staron, Luke Zheng, Gheorghe Doros, et al.
International Journal of Endocrinology|April 17, 2014
Effects of long-term testosterone therapy on patients with "diabesity": results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetesAhmad Haider, Aksam Yassin, Gheorghe Doros, et al.
Journal of Vascular Surgery|April 25, 2017
ReplyMohammad H Eslami, Gheorghe Doros, Denis V Rybin
Journal of Vascular Surgery|September 29, 2009
Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic graftsKaren Woo, Gheorghe Doros, Tina Ng, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 24, 2021
Clinical Characteristics, Treatment Regimens, and Survival in Elderly Patients with AL AmyloidosisJose Acevedo, Gheorghe Doros, Raphael Szalat, et al.
Obesity (Silver Spring, Md.)|March 21, 2013
Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight lossFarid Saad, Ahmad Haider, Gheorghe Doros, et al.
Pharmaceutical Statistics|October 21, 2014
The impact of missing data on the results of a schizophrenia studyDenis Rybin, Gheorghe Doros, Robert Rosenheck, et al.
Social Psychiatry and Psychiatric Epidemiology|December 24, 2005
Recent treatment history vs clinical characteristics in the prediction of use of outpatient psychiatric servicesJohn M de Figueiredo, Heidi Boerstler, Gheorghe Doros
Future Science OA|November 15, 2017
A single center analysis of factors influencing study start-up timeline in clinical trialsBrianna M Krafcik, Gheorghe Doros, Marina A Malikova
Obesity Research & Clinical Practice|August 6, 2014
Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational studyAhmad Haider, Farid Saad, Gheorghe Doros, et al.
Pageof 30

Showing results (11-20 of 291) with videos related to

Sort By:
Pageof 30
Blood Cancer Journal|July 5, 2022
Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian AmericansAndrew Staron, Luke Zheng, Gheorghe Doros, et al.
International Journal of Endocrinology|April 17, 2014
Effects of long-term testosterone therapy on patients with "diabesity": results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetesAhmad Haider, Aksam Yassin, Gheorghe Doros, et al.
Journal of Vascular Surgery|April 25, 2017
ReplyMohammad H Eslami, Gheorghe Doros, Denis V Rybin
Journal of Vascular Surgery|September 29, 2009
Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic graftsKaren Woo, Gheorghe Doros, Tina Ng, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 24, 2021
Clinical Characteristics, Treatment Regimens, and Survival in Elderly Patients with AL AmyloidosisJose Acevedo, Gheorghe Doros, Raphael Szalat, et al.
Obesity (Silver Spring, Md.)|March 21, 2013
Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight lossFarid Saad, Ahmad Haider, Gheorghe Doros, et al.
Pharmaceutical Statistics|October 21, 2014
The impact of missing data on the results of a schizophrenia studyDenis Rybin, Gheorghe Doros, Robert Rosenheck, et al.
Social Psychiatry and Psychiatric Epidemiology|December 24, 2005
Recent treatment history vs clinical characteristics in the prediction of use of outpatient psychiatric servicesJohn M de Figueiredo, Heidi Boerstler, Gheorghe Doros
Future Science OA|November 15, 2017
A single center analysis of factors influencing study start-up timeline in clinical trialsBrianna M Krafcik, Gheorghe Doros, Marina A Malikova
Obesity Research & Clinical Practice|August 6, 2014
Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational studyAhmad Haider, Farid Saad, Gheorghe Doros, et al.
Pageof 30